Weight reduction by mazindol in morbid obesity with or without type 2 diabetes mellitus
Not Applicable
- Conditions
- obesity disease
- Registration Number
- JPRN-UMIN000027557
- Lead Sponsor
- Fukuoka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with contraindication for administration of mazindol or SGLT2 inhibitor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight reduction rate in 3 months' administration of mazindol, with or without the use of SGLT2 inhibitor
- Secondary Outcome Measures
Name Time Method